Financial statements Biopharmacotech
Cash flow statement of Biopharmacotech
Company age:
Age:
3 y. 10 m. 13 d.
Share capital:
Share capital:
10 000 PLN
Cash inflows of BIOPHARMACOTECH
|
Year
|
2021
|
2022
|
|---|---|---|
| Net cash from operating expenses | -873 011,85 | 2 435 922,81 |
| Net cash flow from investing activities | -20 679,25 | -14 415,59 |
| Net cash flow from financial activities | 69 241,82 | -2 401 372,05 |
| Total net cash flow | -824 449,28 | 20 135,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.